BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2010 related articles for article (PubMed ID: 30581271)

  • 1. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
    Eun CS; Kwak MJ; Han DS; Lee AR; Park DI; Yang SK; Kim YS; Kim JF
    BMC Gastroenterol; 2016 Feb; 16():28. PubMed ID: 26922889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
    Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
    Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M; Simms LA; Brown A; Appleyard M; Irwin J; Waddell N; Radford-Smith GL
    J Crohns Colitis; 2019 Mar; 13(4):451-461. PubMed ID: 30445599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
    Walker AW; Sanderson JD; Churcher C; Parkes GC; Hudspith BN; Rayment N; Brostoff J; Parkhill J; Dougan G; Petrovska L
    BMC Microbiol; 2011 Jan; 11():7. PubMed ID: 21219646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.
    Walujkar SA; Kumbhare SV; Marathe NP; Patangia DV; Lawate PS; Bharadwaj RS; Shouche YS
    World J Microbiol Biotechnol; 2018 May; 34(6):76. PubMed ID: 29796862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.
    Cruz-Lebrón A; D'argenio Garcia L; Talla A; Joussef-Piña S; Quiñones-Mateu ME; Sékaly RP; de Carvalho KIL; Levine AD
    J Crohns Colitis; 2020 Jul; 14(6):791-800. PubMed ID: 31758685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Faecal Microbiota in Paediatric Crohn's Disease and Their Dynamic Changes During Infliximab Therapy.
    Wang Y; Gao X; Ghozlane A; Hu H; Li X; Xiao Y; Li D; Yu G; Zhang T
    J Crohns Colitis; 2018 Feb; 12(3):337-346. PubMed ID: 29194468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
    Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
    Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Distinct Gut Microbiota Exists Within Crohn's Disease-Related Perianal Fistulae.
    Haac BE; Palmateer NC; Seaton ME; VanYPeren R; Fraser CM; Bafford AC
    J Surg Res; 2019 Oct; 242():118-128. PubMed ID: 31075656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Terminal-restriction fragment length polymorphism analysis of diversity of mucosa-associated microbiota in patients with Crohn's disease].
    Ran WB; Ouyang Q; Shi W
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2884-9. PubMed ID: 24373401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gastric microbiota in patients with Crohn's disease; a preliminary study.
    Ostrowski J; Kulecka M; Zawada I; Żeber-Lubecka N; Paziewska A; Graca-Pakulska K; Dąbkowski K; Skubisz K; Cybula P; Ambrożkiewicz F; Urasińska E; Mikula M; Starzyńska T
    Sci Rep; 2021 Sep; 11(1):17866. PubMed ID: 34504159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.
    Kang S; Denman SE; Morrison M; Yu Z; Dore J; Leclerc M; McSweeney CS
    Inflamm Bowel Dis; 2010 Dec; 16(12):2034-42. PubMed ID: 20848492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach.
    Manichanh C; Rigottier-Gois L; Bonnaud E; Gloux K; Pelletier E; Frangeul L; Nalin R; Jarrin C; Chardon P; Marteau P; Roca J; Dore J
    Gut; 2006 Feb; 55(2):205-11. PubMed ID: 16188921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.